SGLT2 inhibitors Archives - Drugs in Context

Home SGLT2 inhibitors

Diabetes: how to manage cardiovascular risk in secondary prevention patients

Sarah L Anderson, Joel C Marrs

Article Type

Review

Published

14 Jun 2022

This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.

Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions

Sarah L Anderson, Matteo Bassetti, Arduino A Mangoni

Article Type

Editorial

Published

22 Jan 2021

The Senior Editors of Drugs in Context provide us with their expert opinion on the events of 2020 and what lies ahead in 2021.